Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jun;75(6):1662-1663.
doi: 10.1002/hep.32360. Epub 2022 Feb 10.

Letter to the editor: Chronic liver disease among adolescents and young adults: Alcohol use disorder identification

Gianni Testino  1
Affiliations
Comment

Letter to the editor: Chronic liver disease among adolescents and young adults: Alcohol use disorder identification

Gianni Testino. Hepatology. 2022 Jun.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Paik JM, Kabbara K, Eberly KE, Younossi Y, Henry L, Younossi ZM. Global burden of NAFLD and chronic liver disease among adolescents and young adults. Hepatology. Published online November 6, 2021. https://doi.org/10.1002/hep.32228 - DOI
    1. Scafato E, Caputo F, Patussi V, Balbinot P, Addolorato G, Testino G. The undertreatment of alcohol‐related liver diseases among people with alcohol use disorder. Eur Rev Med Pharmacol Sci. 2020;24(2):974–82.
    1. Scafato E, Ghirini S, Gandin C, Matone A, Vichi M, Scipione R, gruppo di lavoro CSDA (Centro Servizi Documentazione Alcol) . Epidemiologia e monitoraggio alcol‐correlato in Italia e nelle Regioni. Valutazione dell’Osservatorio Nazionale Alcol sull’impatto del consumo di alcol ai fini dell’implementazione delle attività del Piano Nazionale Alcol e Salute. Rapporto 2021. Rome: Istituto Superiore di Sanità; 2021. (Rapporti ISTISAN 21/7)
    1. Decraecker M, Dutartre D, Hiriart JB, Irles‐Depé M, Marraud des Grottes H, Chermak F, et al. Long‐term prognosis of patients with alcohol‐related liver disease or non‐alcoholic fatty liver disease according to metabolic syndrome or alcohol use. Liver Int. 2022;42(2):350–62.
    1. Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol‐associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020;71(1):306–33.